Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
1 clinical trials · Sponsor
◉ Watch Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
| Record | Firm | Date |
|---|---|---|
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction (NCT07203521) | Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd | 2025-11-01 |
Track Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.